Personal Protective Equipment for Infection Control Market size to surpass $26Bn by 2032

Personal Protective Equipment for Infection Control Market size is  anticipated  exceed USD 26 billion by 2032, as per a new research report announced by Global Market Insights Inc.
 

Increasing drug and vaccine R&D is one of the prominent reasons behind the mounting demand for personal protective equipment in healthcare settings. Since novel treatment developments can advance global health, government organizations have been making hefty investments in healthcare technologies. The growing number of emergency department visits due to infectious diseases and the subsequent rise in the progression of interventions for diseases such as COVID-19 will therefore escalate PPE consumption during infection control protocols.
 

During the early stages of the coronavirus pandemic, the requirement for quality-guaranteed PPE surged substantially, leading to stiff competition and severe supply restrictions. PPE kits are also among the medical supplies subject to standard maintenance and mandatory certification. The complexity of manufacturing and the high prices of masks, medical gowns, and other protective clothing may thus hinder industry growth to a certain extent.
 

Rise in elective surgery & healthcare funding to boost use of protective clothing

Personal protective equipment for infection control market share from the protective clothing product segment is likely to register over 2% CAGR up to 2032. The rise in elective surgical procedures across private hospitals and clinics, following a steep decline during the initial months of the COVID-19 outbreak, will drive the progress for protective clothing including surgical gowns. Government funding to support rural healthcare facilities also has increased. The improvement in healthcare infrastructure will further stimulate the need for protective clothing for infection control applications.
 

Browse key industry insights spread across 210 pages with 194 market data tables & 18 figures & charts from the report, “Personal Protective Equipment for Infection Control Market Size By Product (Hands & Arm Protection Equipment {Gloves, Elbow Protectors}, Protective Clothing {Full Body Suits, Surgical Gowns, Vests}, Face Protection Equipment {Respirators and Face Masks, Shields, Eyewear}), By Usability (Reusable, Disposable), By End-use (Hospitals, Ambulatory Surgical Centers, Research and Diagnostic Laboratories), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2023 – 2032” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/ppe-for-infection-control-market
 

Disposable PPE gains ground to prevent cross contamination in healthcare settings

PPE for infection control market revenue from the disposable usability segment exceeded USD 18 billion in 2022,  owing to the ease of use and low contamination attributes associated with medical disposables. Compared to traditional medical supplies, disposable PPE is considered more effective in eliminating infection risks by preventing the growth of microorganisms, bacteria, toxins, and other contaminants. Additionally, with the extensive availability of disinfectants across offline and online pharmacies, the use of disposable personal protective equipment in hospitals and other healthcare settings is likely to surge globally.
 

Rising prevalence of HAIs to augment PPE consumption in hospitals

Personal protective equipment for infection control market value from the hospital end-use segment accounted over USD 14 billion in 2022, considering the increasing rates of hospitalizations and surgeries. This in turn, led to a growing number of facilities reporting HAIs (hospital-acquired infections) across the globe. Such factors have in consequence, bolstered the demand for effective infection control products such as PPE. In addition, the delivery of high-quality care and faster outcomes are encouraging patients to opt for health treatments in hospitals further driving product usage.
 

Burgeoning investment in healthcare to position APAC as a lucrative hub for PPE production

Asia Pacific personal protective equipment for infection control market is set to depict over 2.5% CAGR in 2023, given the surging healthcare expenditure in countries such as Australia and Japan. Health facilities are also garnering considerable regulatory support through a range of government financing or insurance schemes. The report further cites that the escalating out-of-pocket healthcare expenses will stimulate the production of PPE for COVID-19 and other infection control applications across the APAC region.
 

Strategic collaborations among industry players to define competitive landscape

SHIELD Scientific, Medline Industries Inc, B. Braun Melsungen AG, CleanSpace Technology, Dragerwerk AG, SAS Safety Corp, The M Company, Honeywell International, and Gateway Safety are some of the key players profiled in the market.